Toll Free: 1-888-928-9744

United States Pneumonia Vaccine Industry 2018 Market Research Report

Published: Jan 26, 2018 | Pages: 96 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States Pneumonia Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Pneumonia Vaccine in these regions, from 2013 to 2025 (forecast).

United States Pneumonia Vaccine market competition by top manufacturers/players, with Pneumonia Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Pfizer
    Merck
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Pneumococcal Conjugate Vaccine (PCV13)
    Pneumococcal Polysaccharide Vaccine (PPSV23)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Pneumonia
    Meningitis
    Sepsis

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

United States Pneumonia Vaccine Market Report 2018
1 Pneumonia Vaccine Overview
    1.1 Product Overview and Scope of Pneumonia Vaccine
    1.2 Classification of Pneumonia Vaccine by Product Category
        1.2.1 United States Pneumonia Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)
        1.2.2 United States Pneumonia Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        1.2.3 Pneumococcal Conjugate Vaccine (PCV13)
        1.2.4 Pneumococcal Polysaccharide Vaccine (PPSV23)
    1.3 United States Pneumonia Vaccine Market by Application/End Users
        1.3.1 United States Pneumonia Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        1.3.2 Pneumonia
        1.3.3 Meningitis
        1.3.4 Sepsis
    1.4 United States Pneumonia Vaccine Market by Region
        1.4.1 United States Pneumonia Vaccine Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 The West Pneumonia Vaccine Status and Prospect (2013-2025)
        1.4.3 Southwest Pneumonia Vaccine Status and Prospect (2013-2025)
        1.4.4 The Middle Atlantic Pneumonia Vaccine Status and Prospect (2013-2025)
        1.4.5 New England Pneumonia Vaccine Status and Prospect (2013-2025)
        1.4.6 The South Pneumonia Vaccine Status and Prospect (2013-2025)
        1.4.7 The Midwest Pneumonia Vaccine Status and Prospect (2013-2025)
    1.5 United States Market Size (Value and Volume) of Pneumonia Vaccine (2013-2025)
        1.5.1 United States Pneumonia Vaccine Sales and Growth Rate (2013-2025)
        1.5.2 United States Pneumonia Vaccine Revenue and Growth Rate (2013-2025)

2 United States Pneumonia Vaccine Market Competition by Players/Suppliers
    2.1 United States Pneumonia Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
    2.2 United States Pneumonia Vaccine Revenue and Share by Players/Suppliers (2013-2018)
    2.3 United States Pneumonia Vaccine Average Price by Players/Suppliers (2013-2018)
    2.4 United States Pneumonia Vaccine Market Competitive Situation and Trends
        2.4.1 United States Pneumonia Vaccine Market Concentration Rate
        2.4.2 United States Pneumonia Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Pneumonia Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pneumonia Vaccine Sales (Volume) and Revenue (Value) by Region (2013-2018)
    3.1 United States Pneumonia Vaccine Sales and Market Share by Region (2013-2018)
    3.2 United States Pneumonia Vaccine Revenue and Market Share by Region (2013-2018)
    3.3 United States Pneumonia Vaccine Price by Region (2013-2018)

4 United States Pneumonia Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
    4.1 United States Pneumonia Vaccine Sales and Market Share by Type (Product Category) (2013-2018)
    4.2 United States Pneumonia Vaccine Revenue and Market Share by Type (2013-2018)
    4.3 United States Pneumonia Vaccine Price by Type (2013-2018)
    4.4 United States Pneumonia Vaccine Sales Growth Rate by Type (2013-2018)

5 United States Pneumonia Vaccine Sales (Volume) by Application (2013-2018)
    5.1 United States Pneumonia Vaccine Sales and Market Share by Application (2013-2018)
    5.2 United States Pneumonia Vaccine Sales Growth Rate by Application (2013-2018)
    5.3 Market Drivers and Opportunities

6  United States Pneumonia Vaccine Players/Suppliers Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pneumonia Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.2 Pneumonia Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.2 Pneumonia Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    ...

7 Pneumonia Vaccine Manufacturing Cost Analysis
    7.1 Pneumonia Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pneumonia Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pneumonia Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pneumonia Vaccine Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Pneumonia Vaccine Market Size (Value and Volume) Forecast (2018-2025)
    11.1 United States Pneumonia Vaccine Sales Volume, Revenue Forecast (2018-2025)
    11.2 United States Pneumonia Vaccine Sales Volume Forecast by Type (2018-2025)
    11.3 United States Pneumonia Vaccine Sales Volume Forecast by Application (2018-2025)
    11.4 United States Pneumonia Vaccine Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Pneumonia Vaccine
    Figure United States Pneumonia Vaccine Market Size (K Pcs) by Type (2013-2025)
    Figure United States Pneumonia Vaccine Sales Volume Market Share by Type (Product Category) in 2017
    Figure Pneumococcal Conjugate Vaccine (PCV13) Product Picture
    Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
    Figure United States Pneumonia Vaccine Market Size (K Pcs) by Application (2013-2025)
    Figure United States Sales Market Share of Pneumonia Vaccine by Application in 2017
    Figure Pneumonia Examples
    Table Key Downstream Customer in Pneumonia
    Figure Meningitis Examples
    Table Key Downstream Customer in Meningitis
    Figure Sepsis Examples
    Table Key Downstream Customer in Sepsis
    Figure United States Pneumonia Vaccine Market Size (Million USD) by Region (2013-2025)
    Figure The West Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southwest Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Middle Atlantic Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure New England Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The South of US Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Midwest Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Pneumonia Vaccine Sales (K Pcs) and Growth Rate (2013-2025)
    Figure United States Pneumonia Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Pneumonia Vaccine Market Major Players Product Sales Volume (K Pcs) (2013-2018)
    Table United States Pneumonia Vaccine Sales (K Pcs) of Key Players/Suppliers (2013-2018)
    Table United States Pneumonia Vaccine Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Pneumonia Vaccine Sales Share by Players/Suppliers
    Figure 2017 United States Pneumonia Vaccine Sales Share by Players/Suppliers
    Figure United States Pneumonia Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
    Table United States Pneumonia Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table United States Pneumonia Vaccine Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Pneumonia Vaccine Revenue Share by Players/Suppliers
    Figure 2017 United States Pneumonia Vaccine Revenue Share by Players/Suppliers
    Table United States Market Pneumonia Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
    Figure United States Market Pneumonia Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2017
    Figure United States Pneumonia Vaccine Market Share of Top 3 Players/Suppliers
    Figure United States Pneumonia Vaccine Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Pneumonia Vaccine Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Pneumonia Vaccine Product Category
    Table United States Pneumonia Vaccine Sales (K Pcs) by Region (2013-2018)
    Table United States Pneumonia Vaccine Sales Share by Region (2013-2018)
    Figure United States Pneumonia Vaccine Sales Share by Region (2013-2018)
    Figure United States Pneumonia Vaccine Sales Market Share by Region in 2017
    Table United States Pneumonia Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
    Table United States Pneumonia Vaccine Revenue Share by Region (2013-2018)
    Figure United States Pneumonia Vaccine Revenue Market Share by Region (2013-2018)
    Figure United States Pneumonia Vaccine Revenue Market Share by Region in 2017
    Table United States Pneumonia Vaccine Price (USD/Pcs) by Region (2013-2018)
    Table United States Pneumonia Vaccine Sales (K Pcs) by Type (2013-2018)
    Table United States Pneumonia Vaccine Sales Share by Type (2013-2018)
    Figure United States Pneumonia Vaccine Sales Share by Type (2013-2018)
    Figure United States Pneumonia Vaccine Sales Market Share by Type in 2017
    Table United States Pneumonia Vaccine Revenue  (Million USD) and Market Share by Type (2013-2018)
    Table United States Pneumonia Vaccine Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Pneumonia Vaccine by Type (2013-2018)
    Figure Revenue Market Share of Pneumonia Vaccine by Type in 2017
    Table United States Pneumonia Vaccine Price (USD/Pcs) by Types (2013-2018)
    Figure United States Pneumonia Vaccine Sales Growth Rate by Type (2013-2018)
    Table United States Pneumonia Vaccine Sales (K Pcs) by Application (2013-2018)
    Table United States Pneumonia Vaccine Sales Market Share by Application (2013-2018)
    Figure United States Pneumonia Vaccine Sales Market Share by Application (2013-2018)
    Figure United States Pneumonia Vaccine Sales Market Share by Application in 2017
    Table United States Pneumonia Vaccine Sales Growth Rate by Application (2013-2018)
    Figure United States Pneumonia Vaccine Sales Growth Rate by Application (2013-2018)
    Table GlaxoSmithKline Basic Information List
    Table GlaxoSmithKline Pneumonia Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure GlaxoSmithKline Pneumonia Vaccine Sales Growth Rate (2013-2018)
    Figure GlaxoSmithKline Pneumonia Vaccine Sales Market Share in United States (2013-2018)
    Figure GlaxoSmithKline Pneumonia Vaccine Revenue Market Share in United States (2013-2018)
    Table Pfizer Basic Information List
    Table Pfizer Pneumonia Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Pfizer Pneumonia Vaccine Sales Growth Rate (2013-2018)
    Figure Pfizer Pneumonia Vaccine Sales Market Share in United States (2013-2018)
    Figure Pfizer Pneumonia Vaccine Revenue Market Share in United States (2013-2018)
    Table Merck Basic Information List
    Table Merck Pneumonia Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Merck Pneumonia Vaccine Sales Growth Rate (2013-2018)
    Figure Merck Pneumonia Vaccine Sales Market Share in United States (2013-2018)
    Figure Merck Pneumonia Vaccine Revenue Market Share in United States (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Pneumonia Vaccine
    Figure Manufacturing Process Analysis of Pneumonia Vaccine
    Figure Pneumonia Vaccine Industrial Chain Analysis
    Table Raw Materials Sources of Pneumonia Vaccine Major Players/Suppliers in 2017
    Table Major Buyers of Pneumonia Vaccine
    Table Distributors/Traders List
    Figure United States Pneumonia Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure United States Pneumonia Vaccine Revenue  (Million USD) and Growth Rate Forecast (2018-2025)
    Figure United States Pneumonia Vaccine Price (USD/Pcs) Trend Forecast (2018-2025)
    Table United States Pneumonia Vaccine Sales Volume (K Pcs) Forecast by Type (2018-2025)
    Figure United States Pneumonia Vaccine Sales Volume (K Pcs) Forecast by Type (2018-2025)
    Figure United States Pneumonia Vaccine Sales Volume (K Pcs) Forecast by Type in 2025
    Table United States Pneumonia Vaccine Sales Volume (K Pcs) Forecast by Application (2018-2025)
    Figure United States Pneumonia Vaccine Sales Volume (K Pcs) Forecast by Application (2018-2025)
    Figure United States Pneumonia Vaccine Sales Volume (K Pcs) Forecast by Application in 2025
    Table United States Pneumonia Vaccine Sales Volume (K Pcs) Forecast by Region (2018-2025)
    Table United States Pneumonia Vaccine Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Pneumonia Vaccine Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Pneumonia Vaccine Sales Volume Share Forecast by Region in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

To learn more about this report, request a free sample copy

Choose License Type
Single User - US $3800
Multi User - US $7600
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify